Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 2,765.0 | 2,477.8 | 2,846.4 | 2,745.1 | 2,585.3 | 2,405.4 | 2,485.6 | 2,654.6 |
Revenue growth | 11.6% | -12.9% | 3.7% | 6.2% | 7.5% | -3.2% | -6.4% | 6.3% |
Cost of goods sold | 1,865.5 | 1,695.6 | 1,936.3 | 1,857.9 | 1,765.4 | 1,644.5 | 1,676.5 | 1,788.2 |
Gross profit | 899.5 | 782.2 | 910.1 | 887.2 | 819.9 | 760.9 | 809.1 | 866.4 |
Gross margin | 32.5% | 31.6% | 32.0% | 32.3% | 31.7% | 31.6% | 32.6% | 32.6% |
Selling, general and administrative | | | | | | | | |
Sales and marketing | 150.8 | 146.5 | 165.9 | 168.2 | 169.5 | 169.8 | 183.2 | 219.4 |
Research and development | 94.9 | 84.9 | 97.9 | 98.4 | 93.5 | 80.5 | 78.9 | 76.6 |
General and administrative | 214.3 | 198.7 | 241.3 | 253.9 | 258.4 | 260.5 | 258.3 | 300.1 |
EBITA | 535.5 | 263.2 | 433.2 | 374.2 | 338.2 | 296.7 | 394.1 | 266.4 |
EBITA margin | 19.4% | 10.6% | 15.2% | 13.6% | 13.1% | 12.3% | 15.9% | 10.0% |
Amortization of intangibles | 18.9 | 20.4 | 20.8 | 17.6 | 18.9 | 20.1 | 14.0 | |
EBIT | 516.6 | 242.8 | 412.4 | 356.6 | 319.3 | 276.6 | 380.1 | 266.4 |
EBIT margin | 18.7% | 9.8% | 14.5% | 13.0% | 12.4% | 11.5% | 15.3% | 10.0% |
Pre-tax income | 509.1 | 85.2 | 414.4 | 391.0 | 309.4 | 258.4 | 382.3 | 262.0 |
Income taxes | 189.6 | 15.3 | 89.9 | 57.7 | 194.6 | 76.0 | 70.1 | 71.3 |
Tax rate | 37.2% | 18.0% | 21.7% | 14.8% | 62.9% | 29.4% | 18.3% | 27.2% |
Earnings from continuing ops | 316.3 | 72.5 | 325.1 | 333.7 | 228.3 | 182.4 | 312.2 | 190.7 |
Earnings from discontinued ops | | | | | | 4.2 | 39.4 | -3.9 |
Net income | 316.3 | 72.5 | 325.1 | 333.7 | 228.3 | 186.6 | 351.6 | 186.8 |
Net margin | 11.4% | 2.9% | 11.4% | 12.2% | 8.8% | 7.8% | 14.1% | 7.0% |
|
Diluted EPS | $3.66 | $0.83 | $3.67 | $3.76 | $2.57 | $2.03 | $3.44 | $2.05 |
Shares outstanding (diluted) | 86.5 | 87.3 | 88.6 | 88.7 | 89.0 | 89.9 | 90.7 | 92.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|